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Summary.-5-Phenoxysulphonyl-l-methyl-4-nitroimidazole (NSC 38087) can act
as a sensitizer of hypoxic mammalian cells to radiation in vitro. The degree of
sensitization achieved is greater than would be predicted from the drug's electron
affinity. Cytotoxicity studies have shown that5pM NSC38087 can reduce the surviving
fraction of log-phase V79 cells in air at 37°C to 10-2 after 2 h exposure. This toxicity
is considerably increased by small rises in temperature. In contrast to other nitro-
heterocyclic radiosensitizers, NSC 38087 and related 5-substituted 4-nitroimidazoles
show greater toxicity towards aerobic than to hypoxic cells. Log-phase cells show the
highest sensitivity to the toxic action of NSC 38087, with plateau-phase cells, cells
with a history ofchronic hypoxia, andthermotolerant cellsshowinggreaterresistance.
These toxicity data are compared to those for the 2-nitroimidazole hypoxic-cell
sensitizer misonidazole.
THE NITROIMIDAZOLES misonidazole
(MISO) and metronidazole have been used
in clinical trials as potential sensitizers of
the radio-resistant hypoxic cells in tu-
mours. In instances where clinical data
have been evaluable some improvement
in radiation response has been observed
with these compounds (Urtason et al.,
1976; Thomlinson et al., 1976; Dawes et al.,
1978; Ash et al., 1979). However, these
drugs show some neurotoxic effects which
prevent their use at doses sufficient to
give optimal sensitization (Dische et al.,
1977; Urtason et al., 1977). This has led
to a search for sensitizers more effective
than MISO or metronidazole. Interest
has centred on modifying the nitro-
imidazole compounds to produce sensi-
tizers more efficient than MISO but
with similar toxicity (Adams et al.,
1979a, b; Adams et al., 1980a) or alterna-
tively to produce a drug as good a sen-
sitizer as MISO but with lower toxicity
(Brown & Workman, 1980; Brown &
Lee, 1980).
Using mammalian cells cultured in
vitro, it has been shown that electron
affinity is the predominant factor which
determines both the cytotoxicity and
sensitizing effectiveness of hypoxia-
mediated drugs. There are, however, a
number of exceptions to these general
relationships which provide grounds for
optimism that other parameters may be
identified that can affect sensitization by
and toxicity of nitroimidazoles. The com-
pound 5-chloro-1-methyl-4-nitroimida-
zole has previously been shown to sensitize
at concentrations about 100-fold lower
than would have been predicted on the
basis of electron affinity (Watts & Jacobs,
1978). In a subsequent study this anoma-
lously high sensitizing efficiency was
demonstrated for a range of 4-nitro-
imidazoles substituted in the 5-position
with a sulphonate or sulphonamide group
(Adams et al., 1980a, 1981). Among these
compounds, NSC 38087, with the structure
shown in Fig. 1, which has an electron
affinity only slightly greater than that of
MISO, shows a sensitizing efficiency simi-
lar to that of 02. In this paper we examineI. J. STRATFORD, C. WILLIAMSON AND C. HARDY
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FIG. 1. Structure of NSC 38087; 5-phenoxy-
sulplhoniyl-l-metlhyl-nitroimidazole.
the cytotoxic properties of NSC 38087,
and its mode of action is compared to that
ofMISO.
MATERIALS AND METHODS
Cells. Chinese hamster V79-379A cells
used in this work were maintained in spinner
culture in Eagles' minimal essential medium
(MEM) modified for suspension cultures
(Flow Laboratories Ltd.) supplemented with
7.50o foetal calf serum (FCS, Gibco-Biocult
Ltd.). The cells wN-ith a doubling time of
, 10 h were kept in exponential phase at
concentrations ranging between 105 and 106
cells per ml. For most experiments cells were
harvested from asynchronous exponential-
phase cultures. However, occasionally experi-
ments were done on plateau-phase cells, cells
with a history ofchronic hypoxia and thermo-
tolerant cells. Plateau-phase cells were pre-
pared by seeding cultures at 105/ml and
holding in spinner culture at 37°C for 3 days
before use. Cells with a history of chronic
hypoxia were prepared by taking log-phase
cells and holding them at pH 7-4 for 16 h
under anaerobic conditions (Smith et al., 1979;
Rajaratnam et al., 1981). Thermotolerant
cells were prepared by holding log-phase cells
for 16 h at 41°C; under which condition V79
cells are still capable of progression with a
doubling time of22-24 h. These cells are more
resistant to subsequent hyperthermic damage
than cells not receiving the 41°C treatment
(Stratford et al., 1981). All these cell popula-
tions had plating efficiencies 9000 before
cytotoxic treatment.
Cytotoxicity experimen.ts.-250ml spinner
flasks were fitted with a gas inlet/outlet
system and a sidearm through which samples
could be withdrawn. Cells at a concentration
of 2 x 105 cells/ml were suspended in MEM+
7.50o FCS and held in a water bath at 37°C.
The compounds were dissolved in MEM+
7-50o FCS and added to the suspension, which
was buffered with bicarbonate to pH 7-4.
When appropriate, the spinner containing
cells was de-aerated by flowing N2 plus
50o CO2 (< 10 pt/106 02; BOC Ltd.) at
500 ml per min over the surface ofthe stirred
suspension throughout the experiment.
Samples of cells were withdrawn at appro-
priate times, centrifuged, resuspended, coun-
ted and diluted. For each test condition
various numbers of cells were plated, in
triplicate, in MEM+150% FCS and incubated
for 7-10 days at 37°C before scoring for
colony formation. Further details of the
technique are described elsewhere (Stratford
& Adams, 1977).
Radiation experiments-.Cells were har-
vested from exponential-phase cultures,
diluted appropriately and added to glass
Petri dishes containing 2-5 ml MEM, supple-
mented with 15% FCS. Cells were allowed to
attach at 37°C for 1-1 h before the medium
was removed and replaced with fresh medium
containing drug. Irradiations with 60Co
y-rays were carried out in "dural" containers
which can hold 4 Petri dishes (Cooke et al.,
1976). These vessels could be rendered
hypoxic by purging with N2+5% CO2
(BOC Ltd.) for 1 h, when the vessels were
sealed and irradiated at room temperature
at a dose rate of 4-2 Gy/min. For irradiations
in air, cells were equilibrated with air+500
CO2. After irradiation, the medium was
removed and replaced with fresh MEM+150%
FCS and the cells incubated for 7-9 days
before scoring for colony formation.
Compounds.-NSC 38087 was provided by
the Drug Synghesis and Development Branch
of NCI, U.S.A. NSC 326151 was synthesized
in our laboratories.
RESULTS
Fig. 2 illustrates the ability of NSC
38087 to radiosensitize hypoxic mamma-
lian cells in vitro. There is no sensitization
in air. However, under hypoxic conditions,
2uM NSC 38087 (0.52 ,tg/ml) gives an
enhancement ratio, ER, of 1-5, asmeasured
by the ratio of the slopes of the dose-log-
survival curves. The inset to this figure
shows a plot of ER vs concentration of
NSC 38087, and it illustrates that this
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Fia. 2.-Survival data for y-irradiated V79
cells. A,, N2-no drug; 0, N2-2/M NSC
38087; A, aerated cells-no drug; 0,
aerated cells-2,UM NSC 38087. The inset
shows the dependence of enhancement
ratio for irradiated cells on NSC 38087
concentration (data from Adams et al.,
1981).
compound is considerably more efficient
as a sensitizer than MISO.
Not only does NSC 38087 show very
high sensitizing efficiency, but it also
shows considerable cytotoxicity towards
V79 cells held under aerobic conditions
at 37TC. Fig. 3 illustrates the toxicity of
varying concentrations of NSC 38087
plotted as a function of time of exposure
to drug. Data in this and other figures
(unless indicated otherwise) come from
individual experiments; replicate experi-
ments were always done and provided
similar results. It is apparent that the
cytotoxicity of NSC 38087 is both con-
centration and time-dependent. However,
there is an indication that, depending on
the drug concentration, survival reaches a
8
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FIG. 3.-Toxicity of NSC 38087 to aerobic
Chinese hamster V79-379A cells at 370C.
minimum level with longer exposures,
producing no further cell killing (see, e.g.,
data for 3 5,uM NSC 38087). Further
experiments showed that cells exposed to
3 5/tM NSC 38087 for up to 23 h gave a
similar surviving fraction to cells exposed
0
.5-
'I)
Time (h)
FIG. 4.-Survival of cells exposed to various
concentrations of NSC 38087 for various
times under aerobic conditions at 410C.
Data from Fig. 3 (370C), generated in the
same experiment as in this figure, has been
transposed for comparison (----).
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FIGE. 5. Toxicity of 5,ULM NSC .38087 to
hlypoxic (O) afel( aerobic: cells; (A) at :17 C'.
Values +s.e. from 6 experliments (air) and(
4 (N2).
to the same concentration for only 5 h.
The toxicity of NSC 38087 can be poten-
tiated by small rises in temperature. Fig. 4
shows results for various concentrations
of NSC 38087 in air at 4l°C. This tempera-
ture alone causes no change in plating
efficiency for V79 cells over the duration
of these experiments; however, in the
presence of NSC 38087 there is consider-
ably more damage than that at 37°C. This
is illustrated by the data for 35yts NSC
38087, where the 4° rise in temperature
provides a 100-fold increase in cell killing
after contact for 2 h or more.
A compa.rison of the toxicity of 5,uM
NSC 38087 towards hypoxic and aerobic
cells is shown in Fig. 5. At this a.nd other
concentrations (data not shown) the nitro-
imidazole drug is more toxic to aerobic
c \ N2
C:
D -3
LI) 103
0
10~~~~~~~~~
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0 1 2 3 4 5
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FIG. 6.-Toxicity of 50,UM NSC 326151 to
liypoxic an(l aerobic cells at :37°C.
than hypoxic cells. This contrasts with all
previous data for nitro-heterocyclic radio-
sensitizers, which have shown increased
toxicity to hypoxic cells (Sutherland, 1974;
Hall & Roizin-Towle, 1975; Mohindra &
Rauth, 1976; Moore et al., 1976). Other
5-substituted 4-nitroimidazoles which
have sensitizing efficiencies much greater
than would be expected from the electron
affinities also show increased toxicity
towards aerobic cells. Typical ofsuch data
are those given in Fig. 6 for 1 -methyl-4-
nitro - 5 -morpholino - sulphonylimidazole,
NSC 326151. Interestingly, the concentra-
tion of NSC 326151 used in the above
experiment is 10 times greater than for
NSC 38087; yet similar amounts of cell
killing are seen in both air and N2. This
may be due to the higher electron affinity
ofNSC 38087 (see Table).
All the previous experiments were
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TABLE.-Some radiosensitizing and cytotoxic properties of the 5-substititted
4-nitroimidazolest
NSC co(de
38087
:326151
Cl *6 Cl. 6 cc cc
/mmol/dMn3
E71/mV (Cc/Cl-6)*
-342 26x10-3 1 9x 10-1 90x 10-4 1-9x 10(- 0 35
-406 1 5xIt-2 62xx10-1 20xJ10-3 66x10-1 0-13
* For comparison, values ofCc/C1.6 forAIPSO range from 0 3 (Adams et al., 1979b) to 10(WNatts etal., 1980).
t E71 is the one-electron redluction potential measured at pH 7 0; C1.6, C1-6 arc concentrations required to
gixve a radiosensitizer enhancement ratio of 1-6; Cc and Cc are concentrationis requiredl to reduce plating
efficiency by 50% on incubation of cells with drug for 7-10 days. Data for values of E71 and C1.6 are from
Adams et al. (1980a, 1981). C1.6 and Cc are values of sensitizing efficiency andl chronic aerobie toxicity
pre(lictedc from previous electron affinity correlations (Adams et al., 1979a, b).
.o \ plateau phase
V,, -3 exponential 10 phase
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FIG. 7.- Survival of V79 cells wvith different
cultural histories expose(d to 5ytM NSC
38087 under aerobic corn(litions at 37 C.
carried out on cells harvested from expo-
nential-phase cultures. In order to deter-
mine the likely spectrum of effectiveness
of these drugs, cytotoxicity experiments
were done on V79 cells with different cul-
ture histories. Fig. 7 shows the effect of
5jM NSC 38087 on exponential, plateau
and thermotolerant cells, and in addition
on cells with a history of chronic hypoxia.
All treatments were in air at 37TC. Clearly,
the different cell populations respond to
NSC 38087 in widely differing ways, with
exponential cells showing the greatest,
and thermotolerant cells the least sensi-
tivity.
DISCUSSION
NSC 38087 has the typical properties
of a series of 5-sulphonyl derivatives of
1-methyl-4-nitroimidazole. These com-
pounds show much greater sensitizing
efficiency (Adams et al., 1980a, 1981) and
greater toxicity than would be suggested
from their electron affinity. Some sensi-
tization and toxicity data for NSC 38087
and NSC 326151, together with their one-
electron reduction potentials (E17) are
recorded in the Table. Previously it has
been shown for uncharged 5-nitrofurans,
2-nitro- and 5-nitroimidazoles, nitroben-
zenes, quinones and some unsubstituted
4-nitroimidazoles that sensitizingefficiency
and aerobic toxicity correlate extremely
well with the electron affinity of the com-
pounds (Adams et al., 1976a, b, 1979a, b).
Sensitizing efficiencies were defined as the
concentration of drug required to achieve
a given level of enhancement, usually
1-6 (C1.6). These values for the compounds
used in the present work are given in the
table, together with those values (n1.6)
which would have been predicted from
previous electron-affinity correlations.
There are orders-of-magnitude differences
between the observed and predicted sensi-
tizing efficiency. Values for the chronic
aerobic toxicity of NSC 38087 and NSC
326151 are also given. These values are
defined as the concentration of drug
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required to reduce plating efficiency to
50% after 7 days' exposure. As for sensi-
tization, these compounds show much
greater toxicity than would be suggested
from their electron affinity. Nevertheless,
within the series of 5-substituted 4-nitro-
imidazoles, the most electron-affinic com-
pounds still appear the most efficient
sensitizers and also the most toxic.
An interesting feature of the cytotoxic
properties of these compounds is their
greater toxicity to aerobic than to hypoxic
cells. Previously it has been shown that
many other nitro-aromatic compounds are
preferentiallv toxic to hypoxic cells
(Sutherland, 1974; Hall & Roizin-Towle,
1975; Mohindra & Rauth, 1976; Moore
et al., 1976). This has been attributed to
metabolic reduction of the nitro group
(Varghese et al., 1976). Formation of the
nitro-radical anion (RNO-) was shown by
ESR to be the first step in the biological
reduction of nitro-aromatic compounds
(Mason & Holtzman, 1975a). In the pres-
ence of 02, reduction of RNO2 is inhibited
by electron transfer from RNO2 to 02
(Mason & Holtzman, 1975b; Wardman &
Clarke, 1976). Recently it was proposed
that 5-chloro-1-methyl-4-nitroimidazole
and related 5-substituted 4-nitroimida-
zoles, such as those reported here, would
be more toxic towards hypoxic cells than
would be expected on an electron-affinitv
basis (Clarke & Wardman, 1980). These
authors proposed that this could be due to
initial formation of RNO2 followed by
dissociative electron attachment with the
resulting formation of a free radical
or other species, which would be toxic.
This scheme would be inhibited in the
presence of 02 (Clarke & Wardman, 1980).
Therefore, it is now apparent that the
greater toxicity shown by NSC 38087 and
326151 to aerobic cells is Inot wholly con-
sistent with their proposal. Nevertheless,
it is possible that the results reported here
would occur if reductive metabolism of
the nitro group proceeded via an 02-
insensitive mechanism, but this would be
unique to this series of compounds in this
cell line.
One reason for the observed difference
in toxicity to hypoxic and aerobic cells
could be that under hypoxic conditions
metabolism of the drug is more rapid, so
that the form of the drtug that is toxic is
removed from the cellular environment.
The shapes ofsome ofthe hypoxic survival
curves lend support to this argument.
However, we have shown, using HPLC
analysis, that the concentration of free
NSC 326151 in the cell suspensions does
not vary during the course ofthese experi-
ments either in air or N2 (Gibson & Strat-
ford, unpublished). Therefore other rea-
son(s) may have to be sought to explain
the shapes of the survival curves.
At present there is no explanation for
the differential toxicity of these com-
pounds to aerobic cells, nor for their
greater toxicity (in both air and N2) than
would be predicted from their electron
affinities (Adams et al., 1979b, 1980b).
However, it is known that related com-
pounds such as Imuran (azathioprine,
6-(1-methyl-4-nitro-5-imidazolyl) thiopu-
rine) are cleaved rapidly in vivo to 6-
mercaptopurine and 1-methyl-4-nitro-5-
thiolimidazole (Bresnick, 1959; Elion,
1967). This is thought to be due to reaction
offree sulphydryl groups at the 5 position
of the imidazole ring. We are currently
carrying out studies to determine whether
toxicity in vitro, in air and/or N2, is a con-
sequence of such a reaction.
Increases in temperature enhance the
toxicity of nitro-aromatic compounds to
hypoxic and aerobic cells (Stratford et al.,
1978). Potentiation of toxicity by 41°C
hyperthermia is also seen for NSC 38087.
However, any other similarity with the
toxicity of previously studied nitro com-
pounds (e.g. MISO, metronidazole, nitro-
furazone) end there. The shape of the
hypoxic survival curve for MISO shows a
shoulder region after which survival de-
creases exponentially with time; this
clearly differs from many of the curves
shown here. The toxicity of MISO is
similar in exponential phase, plateau phase
and in cells which have been cultured at
41°C. Further, cells with a history of
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chronic hypoxia show a slightly greater
sensitivity to MISO than to exponential-
phase cells (Williamson & Smith, unpub-
lished). This is not the trend in the present
work with NSC 38087, where cells can be
ranked in their sensitivity to this drug as
exponential phase >plateau phase > chron-
ically hypoxic > cells held previously at
41°C. The change in sensitivity is unlikely
to be cell-cycle-associated, since cells held
at 41°C continue to progress through the
cell cycle. Interestingly, the above order
of effectiveness for the toxicity of NSC
38087 is similar to that seen for heat
killing (Stratford et al., 1981). Changes in
heat sensitivity may be due to membrane
alteration. Therefore we could speculate
that the changes in sensitivity to NSC
38087 maybe membrane-associated, which
could subsequently effect drug penetration
and/or metabolism. This is currently
being studied.
We have shown that NSC 38087 and
326151 are highly cytotoxic members of a
series of 5-substituted 4-nitroimidazoles,
and also show very high radiosensitizing
efficiency in vitro. However, as can be seen
from the table, the value C,/Cl.6 is no
better than for MISO. The in vitro data
alone would suggest little therapeutic
advantage over MISO by using these
compounds. However, the value of these
in vitro studies is to give a guide to the
activity of a drug as a sensitizer or cyto-
toxic agent. Current in vivo work is
exploiting metabolic and pharmacokinetic
differences within this series ofcompounds
to take full advantage of the cytotoxic
and radiosensitizing properties of these
drugs.
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